Innate Pharma S.A. (IPHA) PT Raised to $7 at H.C. Wainwright Aug 11, 2026 06:52AM
Leerink Upgrades Innate Pharma S.A. (IPHA) to Outperform Aug 11, 2026 06:11AM
BTIG Assumes Innate Pharma S.A. (ipha) at Buy Mar 11, 2026 04:12PM
H.C. Wainwright Upgrades Innate Pharma S.A. (IPHA) to Buy Oct 29, 2025 06:24AM
Lucid Capital Markets Starts Innate Pharma S.A. (IPHA) at Buy Oct 23, 2025 07:10AM


Sep 18, 2025 03:53AM Leerink Partners Downgrades Innate Pharma S.A. (IPHA) to Market Perform
Jul 28, 2025 06:04AM BTIG Starts Innate Pharma S.A. (IPHA) at Buy
Apr 29, 2025 03:00PM Innate Pharma (IPHA) Highlights Preclinical Anti-Tumor Efficacy Data of Its Antibody Drug Conjugate IPH4502
Apr 24, 2025 07:08AM H.C. Wainwright Reiterates Buy Rating on Innate Pharma S.A. (IPHA)
Mar 28, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Innate Pharma S.A. (IPHA)
Jan 17, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Innate Pharma S.A. (IPHA)
Oct 14, 2024 06:03AM Innate Pharma (IPHA) Appoints Jonathan Dickinson as CEO and Board Chair
Sep 13, 2024 06:46AM H.C. Wainwright Reiterates Buy Rating on Innate Pharma S.A. (IPHA)